BioLASCO Taiwan Co., Ltd.
6662
Rank in Stocks
#26096
BioLASCO Taiwan Co., Ltd., established in Taipei in 1990, operates as an... BioLASCO Taiwan Co., Ltd., established in Taipei in 1990, operates as an international supplier of bio-materials and surgical support services. The company specializes in breeding and producing Specific Pathogen-Free (SPF) laboratory rodents, encompassing various outbreed stocks, inbreed strains, and immune-deficient models, alongside providing bespoke animal model services. Its product portfolio extends to critical diagnostic and research tools, including kits for endotoxin detection, animal health diagnostics, and serological analysis, as well as biological indicators. Furthermore, BioLASCO furnishes a comprehensive array of laboratory equipment vital for animal research and facility management. This sophisticated equipment includes Individually Ventilated Cage (IVC) systems and ventilated housing units, professional automated animal watering systems, transponders, chlorine dioxide gas generators, and specialized devices such as mouse and rat tail cuff blood pressure systems, analgesia equipment, animal behavioral systems, metabolism and behavior tracking systems. The company also offers XPERT cabinet X-ray systems, automatic cleaning equipment, laboratory workstations, isolation chambers, and foggers.
Share Price
$0.86575863
Last synced: 2026-11-10
Market Cap
$22.17M
Change (1 day)
1.43%
Change (1 year)
-14.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioLASCO Taiwan Co., Ltd. (6662)
Category
Healthcare
Operating Margin for BioLASCO Taiwan Co., Ltd. (6662)
Operating Margin as of November 2026 TTM: 17.79%
According to BioLASCO Taiwan Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 17.79%. At the end of 2025 the company had an operating margin of 18.29%.
Operating Margin history for BioLASCO Taiwan Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 17.79% | -2.73% |
| 2025 | 18.29% | -3.94% |
| 2024 | 19.04% | -0.73% |
| 2023 | 19.18% | -16.54% |
| 2022 | 22.98% | -8.81% |
| 2021 | 25.20% | -4.98% |
| 2020 | 26.52% | 29.75% |
| 2019 | 20.44% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -97.83% |
US
|
|
| -149.01% | -108.38% |
US
|
|
| 25.57% | -98.56% |
AU
|
|
| 31.23% | -98.24% |
BE
|
|
| 29.35% | -98.35% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about BioLASCO Taiwan Co., Ltd.'s operating margin
What is BioLASCO Taiwan Co., Ltd.'s operating margin?
BioLASCO Taiwan Co., Ltd.'s operating margin is 17.79%, as of Nov 2026.
What was BioLASCO Taiwan Co., Ltd.'s operating margin in 2025?
In 2025, BioLASCO Taiwan Co., Ltd.'s operating margin was 18.29%, compared with 19.04% in 2024.
How has BioLASCO Taiwan Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, BioLASCO Taiwan Co., Ltd.'s operating margin was highest in 2020 (26.52%) and lowest in 2025 (18.29%).
How does BioLASCO Taiwan Co., Ltd.'s operating margin compare with similar companies?
BioLASCO Taiwan Co., Ltd.'s operating margin (17.79%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.